Geba GP - Search Results

1

Treatment of chronic autoimmune urticaria with omalizumab.

Kaplan AP, Joseph K, Maykut RJ, Geba GP, Zeldin RK. Kaplan AP, et al. Among authors: geba gp. J Allergy Clin Immunol. 2008 Sep;122(3):569-73. doi: 10.1016/j.jaci.2008.07.006. J Allergy Clin Immunol. 2008. PMID: 18774392 Clinical Trial.

2

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.

Massanari M, Nelson H, Casale T, Busse W, Kianifard F, Geba GP, Zeldin RK. Massanari M, et al. Among authors: geba gp. J Allergy Clin Immunol. 2010 Feb;125(2):383-9. doi: 10.1016/j.jaci.2009.11.022. J Allergy Clin Immunol. 2010. PMID: 20159249 Clinical Trial.

3

Adding omalizumab to the therapy of adolescents with persistent uncontrolled moderate--severe allergic asthma.

Massanari M, Milgrom H, Pollard S, Maykut RJ, Kianifard F, Fowler-Taylor A, Geba GP, Zeldin RK. Massanari M, et al. Among authors: geba gp. Clin Pediatr (Phila). 2009 Oct;48(8):859-65. doi: 10.1177/0009922809339054. Epub 2009 Jun 29. Clin Pediatr (Phila). 2009. PMID: 19564449 Clinical Trial.

4

Response of older patients with IgE-mediated asthma to omalizumab: a pooled analysis.

Maykut RJ, Kianifard F, Geba GP. Maykut RJ, et al. Among authors: geba gp. J Asthma. 2008 Apr;45(3):173-81. doi: 10.1080/02770900701247277. J Asthma. 2008. PMID: 18415822

5

Efficacy of omalizumab in cat-allergic patients with moderate-to-severe persistent asthma.

Massanari M, Kianifard F, Zeldin RK, Geba GP. Massanari M, et al. Among authors: geba gp. Allergy Asthma Proc. 2009 Sep-Oct;30(5):534-9. doi: 10.2500/aap.2009.30.3245. Epub 2009 May 22. Allergy Asthma Proc. 2009. PMID: 19467177 Clinical Trial.

6

Effectiveness of omalizumab in reducing corticosteroid burden in patients with moderate to severe persistent allergic asthma.

Karpel J, Massanari M, Geba GP, Kianifard F, Inhaber N, Zeldin RK. Karpel J, et al. Among authors: geba gp. Ann Allergy Asthma Immunol. 2010 Dec;105(6):465-70. doi: 10.1016/j.anai.2010.09.011. Ann Allergy Asthma Immunol. 2010. PMID: 21130385

7

Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor.

Molfino NA, Gossage D, Kolbeck R, Parker JM, Geba GP. Molfino NA, et al. Among authors: geba gp. Clin Exp Allergy. 2012 May;42(5):712-37. doi: 10.1111/j.1365-2222.2011.03854.x. Epub 2011 Sep 23. Clin Exp Allergy. 2012. PMID: 22092535 Review.

8

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.

Busse WW, Massanari M, Kianifard F, Geba GP. Busse WW, et al. Among authors: geba gp. Curr Med Res Opin. 2007 Oct;23(10):2379-86. doi: 10.1185/030079907X226258. Curr Med Res Opin. 2007. PMID: 17711616 Clinical Trial.

9

Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma.

Busse WW, Katial R, Gossage D, Sari S, Wang B, Kolbeck R, Coyle AJ, Koike M, Spitalny GL, Kiener PA, Geba GP, Molfino NA. Busse WW, et al. Among authors: geba gp. J Allergy Clin Immunol. 2010 Jun;125(6):1237-1244.e2. doi: 10.1016/j.jaci.2010.04.005. J Allergy Clin Immunol. 2010. PMID: 20513521 Clinical Trial.

10

A role for platelet release of serotonin in the initiation of contact sensitivity.

Askenase PW, Geba GP, Levin J, Ratzlaff RE, Anderson GM, Ushio H, Ptak W, Matsuda H. Askenase PW, et al. Among authors: geba gp. Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):145-7. doi: 10.1159/000236958. Int Arch Allergy Immunol. 1995. PMID: 7613122 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters